Delivery Order SPE2DB20D1109-SPE2DB25FP67Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Quviviq 50 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,705.59, with completion targeted for August 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,611.45 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Quviviq 25 mg tablets (30-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for Quuviq 50 mg tablets (30-count packaging), with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.67 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. QUVIVIQ is a prescription medication used in the treatment of insomnia, representing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for the supply of fifty milligram Quviviq tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver thirty tablets of the specified medication to a facility in Conshohocken, Pennsylvania between August 11th and 14th, 2023. The Defense Logistics Agency routinely utilizes...
- The Defense Logistics Agency awarded a $369 delivery order to Amerisourcebergen Drug Corporation for 25mg Quviviq tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania under a firm fixed price contract executed on August 2nd and concluding on August 3rd, 2023. The Defense Logistics Agency leverages contracts such as this one to efficiently procure pharmaceuticals in support of the Department of Defense's readiness and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP67ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Quviviq (finerenone) 50 mg tablets in a quantity of 30 units, valued at $1,053.22. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract is set to complete by September 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's portfolio encompasses a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Quviviq—a selective finerenone receptor agonist used in sleep-related hypoventilation treatment—exemplifies the company's role in supplying specialized pharmaceutical products to support Department of Defense healthcare programs globally. The Prime Vendor Global Program vehicle under which this order was placed enables AmerisourceBergen to serve multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |